The mechanism appears to involve interaction with the endogenous opioid systemDSIP modulates enkephalin and beta-endorphin release, suggesting opioid-system cross-talk
It is contraindicated in people with cardiovascular disease, uncontrolled hypertension, or a history of drug misuse, and must not be taken with monoamine oxidase inhibitors (MAOIs) due to the risk of hypertensive crisis
Such a decrease was observed in serum levels of fasting insulin and HOMA-IR in the vitamin B12 group, although this change did not reach a significant level
In preclinical and in vitro studies, GHK-Cu is being researched in relation to collagen formation in skin cells, antioxidant and inflammation-related processes, tissue repair and the regulation of gene expression
A comprehensive analysis is imperative before considering this peptide for therapeutic applications
Collagen and Extracellular Matrix Remodeling Much of the dermatologic interest in GHK-Cu stems from its role in the extracellular matrix (ECM)